Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema The INSIGHT Randomized Clinical Trial /

Bressler Susan B., Barve Abhijit, Ganapathi Prasanna C., Beckmann Katrin, Apte Rajendra S., Marcus Dennis M., Baumane Kristine, Agarwal Somesh, Oleksy Piotr, Reichstein David A., Patel Sunil S., Ernest Jan, Dégi Rózsa, Gupta Vishali, Kishino Genichiro, Kamei Motohiro, Loganathan Subramanian, Kollaborációs szervezet: INSIGHT Study Group, et al
2024

Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema 48-week subgroup analysis of the PHOTON trial /

Suzuma Kiyoshi, Murata Toshinori, Shimura Masahiko, Yoshida Shigeo, Kishino Genichiro, Berliner Alyson J, Chu Karen W, Reed Kimberly, Vitti Robert, Cheng Yenchieh, Voronca Delia, Bhore Rafia, Leal Sergio, Morgan-Warren Peter, Schulze Andrea, Schmidt-Ott Ursula, Kobayashi Masato, Sakamoto Taiji, Kollaborációs szervezet PHOTON Investigators, Tóth-Molnár Edit, et al
2026